Artking Global Limited reduced its holdings in SIMCERE PHARMA (02096) by 14 million shares at a price of HK$6.1 per share.
On November 14, Artking Global Limited reduced its holdings of Sinopharm Group (02096) by 14 million shares, at a price of 6.1 Hong Kong dollars per share, with a total amount of 85.4 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 14, Artking Global Limited reduced its holdings of SIMCERE PHARMA (02096) by 14 million shares, with a price of 6.1 Hong Kong dollars per share, for a total amount of 85.4 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 1.788 billion shares, with a new shareholding percentage of 70.75%.
Related Articles
Sino Medical Sciences Technology Inc. (688108.SH): Spinal Fracture Balloon Product Obtains Foreign Medical Device Registration Certificate.
Bank of America Securities: Raise Weichai Power (02338) target price to 21.5 Hong Kong dollars, third-quarter net profit beats expectations.
Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary receives registration certificate for Butorphanol Tartrate Injection.
Sino Medical Sciences Technology Inc. (688108.SH): Spinal Fracture Balloon Product Obtains Foreign Medical Device Registration Certificate.
Bank of America Securities: Raise Weichai Power (02338) target price to 21.5 Hong Kong dollars, third-quarter net profit beats expectations.
Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary receives registration certificate for Butorphanol Tartrate Injection.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
